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ABSTRAK
Eosinophilic gastroenteritis, penyakit inflamasi yang tidak diketahui puncanya, 
biasanya melibatkan infiltrasi eosinophilic ke dalam perut dan usus kecil. Di sini, kami 
menerangkan kes gastroenteritis eosinophilic yang jarang berlaku yang melibatkan 
keseluruhan saluran penghadaman sebagai manifestasi sindrom hypereosinophilic. 
Seorang wanita berusia 22 tahun datang dengan cirit-birit, lelehan pleural, ascites 
dan eosinophil darah periferi yang tinggi. Spesimen najis adalah negatif untuk 
parasit, ova, bakteria dan kulat. Kajian endoskopi menunjukkan pangastritis dan 
duodenitis. Spesimen biopsi esofagus, perut, duodenum, usus kecil, dan kolon 
menunjukkan penyusupan eosinophilic. Diagnosa sindrom hypereosinophilic 
dengan  gastroenteritis eosinophilic melibatkan saluran penghadaman keseluruhan 
telah dibuat. Oleh itu, pesakit telah dirawat dengan prednisolone. Gejala dan 
eosinophilia periferal sembuh dengan rawatan, dan penyiasatan radiologi 
menunjukkan lelehan pleura hilang selepas rawatan. Kes ini menggambarkan 
spektrum penyakit ini, di mana ia melibatkan saluran pencernaan keseluruhan dan 
ia juga menekankan kepentingan diagnostik biopsi endoskopi.
Kata kunci: sindrom hipereosinofilik, radang sistem gastrousus, biopsi endoskopik, 
kortikosteroid 
ABSTRACT
Eosinophilic gastroenteritis, an inflammatory disease of unknown etiology, 
commonly involves the stomach and small intestine with eosinophilic infiltration. 
Here, we report an unusual case of eosinophilic gastroenteritis involving the 
entire digestive tract as a manifestation of hypereosinophilic syndrome (HES). A 
22-year-old woman presented to us with diarrhoea, pleural effusion, ascites and 
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marked peripheral oeosinophilia. Stool specimens were negative for parasites, 
ova, bacteria, and fungi. Endoscopic studies showed pangastritis and duodenitis. 
Biopsy specimens of the oesophagus, stomach, duodenum, ileum, and colon 
demonstrated oeosinophilic infiltration. A diagnosis of hypereosinophilic syndrome 
with eosinophilic gastroenteritis involving the entire digestive tract was made. 
Hence, she was treated with prednisolone. Symptoms and peripheral oeosinophilia 
rapidly resolved with treatment, and radiological investigations revealed resolution 
of effusion. This case illustrates the wide spectrum of clinical manifestation of the 
disease, whereby it involves the entire digestive tract and it also emphasizes the 
diagnostic yields of endoscopic biopsies. 
Keywords: hypereosinophilic syndrome, oeosinophilic gastroenteritis, endoscopic 
biopsies, corticosteroids
CASE REPORT
A 22-year-old lady with a past medical 
history of well controlled eczema and 
asthma presented with a history of 
diarrhoea, vomiting and abdominal 
pain for one week. The initial blood 
investigations showed leucocytosis with 
marked eosinophilia (TWC of 41.2 with 
eosinophil of 69%) (Figure 1). She was 
treated initially as acute gastroenteritis 
with intravenous fluid and antibiotics 
but her symptoms persisted. Over 
the span of few days, she developed 
dyspnoea. Her chest radiograph and 
CT scan of her chest and abdomen 
revealed bilateral pleural effusion and 
ascites. She also developed purpuric 
rashes over the dorsum of her hands 
associated with joint pain. 
 Her blood, stool and urine cultures 
were negative. Stool specimens were 
also negative for ova and cysts. In 
view of her persistent diarrhoea, 
patient underwent an upper and lower 
gastrointestinal endoscopy. Her upper 
endoscopy showed pangastritis and 
INTRODUCTION
Eosinophilic gastroenteritis (EG) is 
a rare manifestation of HES with a 
frequency of around 25% (Rothenberg 
2004). The clinical features of EG 
varies is based on the region and 
depth of the gastrointestinal tract (GIT) 
affected by the eosinophilic infiltration 
(Rothenberg 2004; Shifflet et al. 2009; 
Freeman 2008; Conus & Simon 2008). 
The common symptoms include 
abdominal pain, diarrhea and vomiting.
The definitive diagnosis of EG requires 
histological evidence of eosinophilic 
infiltration of >20 eosinophils/high-
powered field in the lamina propria 
(Rothenberg 2004; Shifflet et al. 2009; 
Liacouras 2007). The main aim of the 
treatment is to reduce the eosinophil 
counts. In general, the majority of 
patients respond well to steroid therapy 
(Conus & Simon 2008; Liacouras 2007; 
Chen et al. 2003). However, relapses 
are common and such patients may 
require long term immunosuppressive 
agents (Chen et al. 2003).
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duodenitis. The gastric and duodenal 
biopsies showed significant oeosinophil 
infiltration (>20 per high power field) 
each (Figure 2). Her colonoscopy 
revealed mild ileitis and pancolitis 
predominantly involving the descending 
and sigmoid colon. The biopsies taken 
throughout the colon and terminal 
ileum also demonstrated presence 
of mild to moderate infiltration of the 
lamina propia by eosinophils of >30 per 
high power field (Figure 3 and 4). A skin 
biopsy revealed scattered eosinophils 
at the periadnexal and perivascular 
area. Bone marrow trephine exhibited 
increased number of eosinophils and 
its precursors. No malignant cells were 
observed. 
 Hence, the provisional diagnosis was 
idiopathic hypereosinophilic syndrome 
with oeosinophilic gastroenteritis, 
cutaneous involvement and serositis. 
The patient was started on prednisolone 
0.5mg/kg and the dose was tapered 
slowly over the next four weeks. She 
was discharged well and six weeks after 
treatment, she was asymptomatic and 
her serositis had resolved. Her total white 
count normalized and the percentage of 
oeosinophils reduced to 9%.
DISCUSSION
Idiopathic hypereosinophilic 
syndrome (HES) constitutes a rare 
and heterogeneous group of disorders 
Figure 1 : Full blood picture showed marked eosinophilia (arrows)
Figure 2: Histopathological examination of the esophagus and gastric mucosae showed 
eosinophilic infiltration >20 per high power field
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with unknown prevalence (Roufosse 
et al. 2007). The term HES was first 
introduced by Hardy and Anderson 
in 1968 and in 1975, Chusid et al 
established four diagnostic criteria for 
idiopathic HES (Roufosse et al. 2007; 
Kahn et al. 2008; Klion 2005) namely 
the presence of i) blood eosinophilia 
>1500/mm3 for at least six months, 
ii) absence of an underlying cause 
of oeosinophilia despite extensive 
evaluation, and iii) presence of end 
organ damage or dysfunction related 
to the oeosinophilia. HES has a 
predilection for the skin, heart and 
nervous system but almost any tissue 
or organ can be affected. Of note, 
the cardiovascular and hematological 
systems account for more than 50% of 
the disease manifestation (Roufosse et 
al. 2007). The onset of HES is generally 
between the age of 20-50 years  with 
male preponderance (Freeman 2008; 
Klion 2005).
 About 25% of HES patients have 
oeosinophilic infiltration of the 
gastrointestinal tract which may involve 
almost any region from the esophagus 
to rectum (Freeman 2008). Although 
the oeosinophilic infiltration in EG can 
involve any part of the gastrointestinal 
tract, this disease is characterized by 
predominant involvement of the gastric 
and small intestinal mucosa (Rothenberg 
Figure 3: Colonoscopy showed mild ileitis with pancolitis, predominantly involving the 
descending, sigmoid colon with no loss of vascular pattern
Figure 4: Histopathological examination of rectum and terminal ileum showed presence of mild to 
moderate eosinophilic infiltration of thelamina propia of > 30 per high power field
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2004). EG as the initial manifestation of 
HES with such extensive involvement 
of the entire digestive tract is extremely 
rare. 
 The exact etiology of EG is unknown 
but up to 40% cases were associated 
with underlying allergies or atopy 
namely food allergies, eczema, allergic 
rhinitis and asthma (Chen et al. 2003; 
Nair et al. 2011). The elevated Ig E levels 
in the sera of affected patients implies 
that atopy maybe involved in the 
pathogenesis of EG (Rothenberg 2004; 
Chen et al. 2003). In the present case, 
the patient had asthma and eczema.
 Iron deficiency associated with 
blood loss as well as protein-losing 
enteropathy are known complications 
of this disease entity. If muscular layers 
are involved, intestinal obstruction may 
ensue, while serosal involvement may 
be associated with ascites (Rithenberg 
2004; Freeman 2008; Chen et al. 2003). 
The endoscopic appearance of EG is 
nonspecific. The abnormal findings 
include erythematous mucosa, friable, 
nodular, and ulcerative changes. In 
a retrospective study by Chen et al. 
(2003) involving 15 patients with EG, 
10 of the patients had only nonspecific 
gastritis or colitis while two patients had 
shallow gastritis and duodenal ulcers 
(Chen et al. 2003).
 Definitive diagnosis requires 
histological evidence of eosinophilic 
infiltration. Oeosinophilic infiltration 
is usually patchy in distribution and 
may be present in otherwise normal, 
non-inflamed bowel wall (Rothenberg 
2004; Chen et al. 2003). Because of 
this, multiple biopsies should be taken 
to improve diagnostic yield. For the 
purpose of deriving the diagnosis of 
EG, the majority of studies have used 
a definition of >20 oeosinophils/ high-
powered field in the lamina propria 
(Rothenberg 2004; Shifflet et al. 2009; 
Liacouras 2007). 
 The evidence for the management of 
EG is largely based on case studies and 
retrospective studies (Liacouras 2007; 
Chen et al. 2003). Presently, there is 
no randomized trial on its treatment 
because of the rarity of the disease 
(Liacouras 2007). The main aim of the 
management of EG is to reduce the 
oeosinophil counts. In general, patients 
respond rapidly to steroids (Conus & 
Simon 2008; Liacouras 2007; Chen et al. 
2003). However, the optimal duration 
of the steroid therapy is unknown 
but Chen et al. (2003) demonstrated 
that short courses of steroid therapy 
followed by repeated courses for 
relapses gave promising results in 
treating EG (Chen et al. 2003). Our 
patient was treated with prednisolone 
0.5 mg per kg for two weeks which was 
tapered after two weeks. This regime 
resulted in marked symptomatic and 
radiological improvement. For patients 
who have frequent relapses of EG, 
long term immunosuppressive agents 
or low dose corticosteroids is strongly 
recommended (Chen et al. 2003). 
Few authors have described the use 
of sodium cromoglycate (a stabilizer of 
mast cell membranes) or montelukast 
(a selective, competitive leukotriene 
receptor antagonist) as steroid-sparing 
agents (Schwartz et al. 2001).
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